Figure 1
The small-molecule inhibitor ML162 targeting Sec46 of human GPX4. The (S)-enantiomer (stereocenter depicted in green, covalent warhead α-chloroacetamide in blue) is shown. The postulated product of the covalent reaction with Sec46 of GPX4WT is shown on the right. |